| Code | Description | Claims | Beneficiaries | Total Paid |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
303 |
269 |
$158K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,551 |
717 |
$102K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,947 |
2,365 |
$99K |
| 99215 |
Prolong outpt/office vis |
1,018 |
802 |
$47K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
306 |
151 |
$37K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,589 |
1,181 |
$36K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,484 |
3,665 |
$31K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
878 |
504 |
$14K |
| 96367 |
|
494 |
257 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
4,671 |
2,433 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
291 |
158 |
$9K |
| 77300 |
|
27 |
25 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
491 |
147 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
487 |
221 |
$3K |
| 77338 |
|
13 |
13 |
$3K |
| 96415 |
|
100 |
51 |
$2K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
33 |
25 |
$2K |
| 96417 |
|
23 |
13 |
$951.23 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
80 |
40 |
$185.76 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
228 |
116 |
$117.63 |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
53 |
53 |
$0.00 |